When do biologic drug patents expire and when will biosimilars launch?

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Genzyme	LEMTRADA	alemtuzumab	INJECTABLE;INJECTION	103948	003	2001-05-07	➤ Sign Up	Burroughs Wellcome Co. (Research Triangle Park, NC)	➤ Sign Up	RX	Orphan	company
Genzyme	LEMTRADA	alemtuzumab	INJECTABLE;INJECTION	103948	003	2001-05-07	➤ Sign Up	Burroughs Wellcome Co. (Research Triangle Park, NC)	➤ Sign Up	RX	Orphan	company
Genzyme	LEMTRADA	alemtuzumab	INJECTABLE;INJECTION	103948	003	2001-05-07	➤ Sign Up	Burroughs Wellcome Co. (Research Triangle Park, NC)	➤ Sign Up	RX	Orphan	company
Genzyme	LEMTRADA	alemtuzumab	INJECTABLE;INJECTION	103948	003	2001-05-07	➤ Sign Up	British Technology Group Limited (London, GB)	➤ Sign Up	RX	Orphan	company
Genzyme	LEMTRADA	alemtuzumab	INJECTABLE;INJECTION	103948	003	2001-05-07	➤ Sign Up	Allergan, Inc. (Irvine, CA)	➤ Sign Up	RX	Orphan	company
Genzyme	LEMTRADA	alemtuzumab	INJECTABLE;INJECTION	103948	003	2001-05-07	➤ Sign Up	BTG International Limited (London, GB)	➤ Sign Up	RX	Orphan	company
Genzyme	LEMTRADA	alemtuzumab	INJECTABLE;INJECTION	103948	003	2001-05-07	➤ Sign Up	Allergan, Inc. (Irvine, CA)	➤ Sign Up	RX	Orphan	company
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

Biologic Drugs With Dosage Form: INJECTABLE;INJECTION